Abstract
Macrophages produce reactive oxygen species (ROS) and reactive nitrogen species (RNS) in response to bacterial infections. Mycobacteria are relatively resistant to ROS, but RNS inhibit growth of, and possibly even kill, mycobacteria in activated macrophages. We recently constructed aMycobacterium marinum mel2locus mutant, which is known to affect macrophage infection. We found previously that themel2locus confers resistance to ROS and RNS in laboratory medium, suggesting that this locus might play a similar role during growth in macrophages. Since J774A.1 murine macrophages produce high levels of ROS and RNS upon activation with gamma interferon (IFN-γ), we examined the effects of IFN-γ on ROS and RNS production by these cells as well as the effects on growth ofM. marinumin these cells. We found that anM. marinummutant with mutation of the first gene in themel2locus,melF, is defective for growth in IFN-γ-plus-lipopolysaccharide-treated J774A.1 cells and that this defect is abrogated by the presence of either inhibitors of nitric oxide synthase or ROS scavengers. Furthermore, theM. marinum melFmutant displays a defect at late stages in the mouse footpad model of infection. These phenotypic characteristics could be complemented fully by the entiremel2locus but only partially by the presence ofmelFalone, supporting data suggesting that this insertion mutation has polar effects on downstream genes in themel2locus. These observations demonstrate that theM. marinum mel2locus plays a role in resistance to ROS and RNS produced by activated macrophages.

This publication has 53 references indexed in Scilit: